-
Loading metrics
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp
- Daniele Veggi,
- Federica Bianchi,
- Laura Santini,
- Paola Lo Surdo,
- Chelsy C. Chesterman,
- Werner Pansegrau,
- Nicoletta Bechi,
- Ying Huang,
- Vega Masignani,
-
Mariagrazia Pizza,
Roles Conceptualization, Formal analysis, Writing – review & editing
Affiliation GSK, Siena, Italy
⨯ - Rino Rappuoli,
-
Matthew J. Bottomley,
Roles Conceptualization, Formal analysis, Supervision, Writing – original draft, Writing – review & editing
Affiliation GSK, Rockville, MD, United States of America
⨯ - Roberta Cozzi ,
-
Domenico Maione
Roles Conceptualization, Supervision, Writing – review & editing
* E-mail: roberta.x.cozzi@gsk.com (RC); domenico.x.maione@gsk.com (DM)
Affiliation GSK, Siena, Italy
⨯
http://orcid.org/0000-0003-4509-1519
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp
- Daniele Veggi,
- Federica Bianchi,
- Laura Santini,
- Paola Lo Surdo,
- Chelsy C. Chesterman,
- Werner Pansegrau,
- Nicoletta Bechi,
- Ying Huang,
- Vega Masignani,
- Mariagrazia Pizza
x
-
- Published: October 2, 2020
- https://doi.org/10.1371/journal.ppat.1008882